Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 50/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street sentiment is generally neutral. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
HIFS demonstrates strong business quality with robust profitability and healthy margins. However, this is severely offset by a highly leveraged balance sheet (Debt/EBITDA > 4.0x) and elevated financial risk.
The company maintains stable top-line performance paired with robust earnings compounding (13.3% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 30.7% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $66.8M | +8.9% | — | — | +14.1% | |
| EBITDA | $27.0M | — | +10.2% | — | — | |
| Net Income | $20.7M | +93.5% | +13.3% | — | +10.9% | |
| EPS (Diluted) | $9.39 | +92.7% | +13.3% | +1.3% | +10.6% | |
| Free Cash Flow | $7.5M | +202.2% | -12.7% | -4.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 43.6% | 35.7% | 53.3% | 63.6% |
| Operating Margin | 30.7% | 22.0% | 37.4% | 44.8% |
| Net Margin | 23.0% | 16.6% | 27.2% | 31.0% |
| FCF Margin | 15.0% | 10.0% | 24.3% | 29.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | — | $4.79 | — | ||
| Q1'26 | — | $4.54 | — | ||
| Q4'25 | — | $3.86 | — | ||
| Q3'25 | — | $3.39 | — | ||
| Q2'25 | — | $2.78 | — | ||
| Q1'25 | — | $2.16 | — | ||
| Q4'24 | — | $1.44 | — | ||
| Q3'24 | — | $1.00 | — |
Total return is +27.7% (1Y), outperforming the benchmark by +2.7%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +5.5% | -3.8% | — |
| 1Y | +27.7% | +2.7% | +1.4% |
| 3YCAGR | +11.9% | -8.0% | +3.9% |
| 5YCAGR | +0.8% | -12.2% | +5.0% |
| 10YCAGR | +9.5% | -4.3% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Hingham Institution for Savings (HIFS) valuation, health, and returns.
Based on peer relative multiples, Hingham Institution for Savings appears Slightly expensive versus peers compared to industry peers.
Hingham Institution for Savings has multiple valuation anchors: Peer Relative Fair Value: $251.19. A convergence of these signals offers higher conviction.
Hingham Institution for Savings displays fair financial health with a composite quality score of 50/100, supported by a Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 2.8%.
Hingham Institution for Savings pays a 0.9% dividend yield, covered by a 10% payout ratio with 1 years of growth, supplemented by a 0.0% buyback yield.
Hingham Institution for Savings's current growth trajectory is Decelerating. The company achieved +8.9% 1Y revenue growth and +92.7% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for Hingham Institution for Savings include: -21.3% 1-year max drawdown. Volatility risk is characterized by a beta of 1.13x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.